http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106890332-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
filingDate 2017-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106890332-B
titleOfInvention Thermo-sensitive gold nanocage hydrogel drug delivery system with photothermal chemotherapy precise and synergetic anti-tumor effect
abstract The invention discloses a preparation method of a thermo-sensitive gold nanocage hydrogel drug delivery system with accurate synergic anti-tumor effect in photothermal chemotherapy, which comprises the following steps: 1) mixing the gold nanocages with the high-temperature ligand, stirring, incubating, and centrifuging to obtain the gold nanocages modified by the high-temperature ligand; wherein the high-temperature ligand is a chain temperature-sensitive polymer containing a disulfide bond, and the phase transition temperature of the high-temperature ligand is 39-50 ℃; 2) dispersing the high-temperature ligand-modified gold nanocages obtained in the step 1) in an ammonium sulfate solution, stirring, centrifuging, dispersing the solid in an adriamycin aqueous solution, and standing in a dark place to obtain drug-loaded gold nanocages; 3) mixing the drug-loaded gold nanocages obtained in the step 2) with a low-temperature ligand, stirring, incubating, and centrifuging to obtain a thermo-sensitive gold nanocage hydrogel drug-loaded system with accurate synergetic anti-tumor effect in photothermal chemotherapy; wherein the low-temperature ligand is a chain temperature-sensitive polymer containing a disulfide bond, and the phase transition temperature of the low-temperature ligand is 26-35 ℃.
priorityDate 2016-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393782
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411288578
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62652
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413857819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458357694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474364
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447827115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3571582
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28015
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16637
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482532689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449559927
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420500386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450458738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23968
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58918144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413369487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449545084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409500530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415911620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76299
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425769382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6422
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23690424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411168116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID263094

Total number of triples: 66.